Epidemiology of urinary melatonin in women and its relation to other hormones and night work

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 6, 2004, Pages 936-943

  Schernhammer, Eva S ^a,b,c,f   Rosner, Bernard ^a,b   Willet, Walter C ^a,b   Laden, Francine ^a,b   Colditz, Graham A ^a,b,d,e   Hankinson, Susan E ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^d DANA FARBER HARVARD CANCER CENTER   (United States)

^e HARVARD CENTER FOR CANCER PREVENTION   (United States)

^f CHANNING LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTRONE; ESTRONE SULFATE; MELATONIN; PRASTERONE; PRASTERONE SULFATE; PROLACTIN; TESTOSTERONE;

ADULT; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RISK; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; LIGHT DARK CYCLE; NIGHT; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SHIFT WORKER; URINALYSIS;

ADULT; ANDROSTENEDIONE; ANDROSTENOLS; BIOLOGICAL AVAILABILITY; BIOLOGICAL MARKERS; BODY MASS INDEX; BREAST NEOPLASMS; COHORT STUDIES; CREATININE; DEHYDROEPIANDROSTERONE; ESTRADIOL; ESTRONE; FEMALE; HORMONES; HUMANS; LIGHT; MELATONIN; MIDDLE AGED; NURSES; PROLACTIN; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SPECIMEN HANDLING; STEROIDS; WORK SCHEDULE TOLERANCE;

EID: 2942536034     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Joechle W. Trends in photophysiologic concepts. Ann NY Acad Sci 1964;117:88-104.
2. Czeisler CA, Duffy JF, Shanahan TL, et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999;284:2177-81.
3. Lynch HJ, Wurtman RJ, Moskowitz MA, Archer MC, Ho MH. Daily rhythm in human urinary melatonin. Science 1975;187:169-71.
4. Waldhauser F, Dietzel M. Daily and annual rhythms in human melatonin secretion: role in puberty control. Ann NY Acad Sci 1985;453:205-14.
5. Waldhauser F, Weiszenbacher G, Frisch H, Zeitlhuber U, Waldhauser M, Wurtman RJ. Fall in nocturnal serum melatonin during prepuberty and pubescence. Lancet 1984;18:362-5.
6. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336:186-95.
7. Schernhammer ES, Laden F, Speizer FE, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. J Natl Cancer Inst 2001;93:1563-8.
8. Schernhammer ES, Laden F, Speizer FE, et al. Night-shift work and risk of colorectal cancer in the Nurses' Health Study. J Natl Cancer Inst 2003;95:825-88.
9. Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 2001;93:1557-62.
10. Hansen J. Increased breast cancer risk among women who work predominantly at night. Epidemiology 2001;12:74-7.
11. Czeisler CA, Dijk DJ. Chapter 20: Human circadian physiology and sleep-wake regulation. In: Takahashi JS, Turek FW, Moore RY, editors. Handbook of behavioral neurobiology: circadian clocks. New York: Plenum Publishing Co.; 2001. p. 531-569.
12. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-61.
13. Wetterberg L. Melatonin in humans physiological and clinical studies. J Neural Transm Suppl 1978;13:289-310.
14. Nowak R, McMillen IC, Redman J, Short RV. The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol 1987;27:445-52.
15. Lang U, Kornemark M, Aubert ML, Paunier L, Sizonenko PC. Radioimmunological determination of urinary melatonin in humans: correlation with plasma levels and typical 24-hour rhythmicity. J Clin Endocrinol & Metab 1981;53:645-50.
16. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocrinol & Metab 1985;60:1166-73.
17. Cook MR, Graham C, Kavet R, Stevens RG, Davis S, Kheifets L. Morning urinary assessment of nocturnal melatonin secretion in older women. J Pineal Res 2000;28:41-7.
18. Baskett JJ, Cockrem JF, Antunovich TA. Sulphatoxymelatonin excretion in older people: relationship to plasma melatonin and renal function. J Pineal Res 1998;24:58-61.
19. Graham C, Cook MR, Kavet R, Sastre A, Smith DK. Prediction of nocturnal plasma melatonin from morning urinary measures. J Pineal Res 1998;24:230-8.
20. Levallois P, Dumont M, Touitou Y, et al. Effects of electric and magnetic fields from high-power lines on female urinary excretion of 6-sulfatoxymelatonin. Am J Epidemiol 2001;154:601-9.
21. Stevens RG, Davis S, Mirick DK, Kheifets L, Kaune W. Alcohol consumption and urinary concentration of 6-sulfatoxymelatonin in healthy women. Epidemiology 2000;11:660-5.
22. Travis RC, Allen NE, Peeters PHM, van Noord PAH, Key TJ. Reproducibility over 5 years of measurements of 6-sulphatoxymelatonin in urine samples from postmenopausal women. Cancer Epidemiol Biomarkers 2003;12:806-8.
23. Davis S, Kaune WT, Mirick DK, Chen C, Stevens RG. Residential magnetic fields, light-at-night, and nocturnal urinary 6-sulfatoxymelatonin concentration in women. Am J Epidemiol 2001;154:591-600.
24. Colditz GA, Manson JE, Hankinson SE. The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 1997;6:49-62.
25. Hankinson SE, London SJ, Chute CG, et al. Effect of transport conditions on the stability of biochemical markers in blood. Clin Chem 1989;35:2313-6.
26. Hankinson SE, Manson JE, Speigelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3 year period. Cancer Epidemiol, Biomarkers & Prev 1995;4:649-54.
27. The Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002,94:606-16.
28. Hankinson SE, Willett WC, Manson JE, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1998;90:1292-9.
29. Rockhill B, Willett WC, Hunter DJ, et al. Physical activity and breast cancer risk in a cohort of young women. J Natl Cancer Inst 1998;90:1155-60.
30. Hankinson SE, Willett WC, Colditz GA, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998;351:1393-6.
31. Hankinson SE, Willett WC, Michaud DS, et al. Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:629-34.
32. Inc. SAS/STAT user's guide version 6.4. Cary, NC: SAS Institute.
33. Michaud DS, Manson JE, Spiegelman D, et al. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period. Cancer Epidemiol, Biomarkers & Prev 1999;8:1059-64.
34. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983;25:165-72.
35. Fernandez B, Malde JL, Montero A, Acuna D. Relationship between adenohypophyseal and steroid hormones and variations in serum and urinary melatonin levels during the ovarian cycle, perimenopause and menopause in healthy women. J Steroid Biochem 1990;35:257-62.
36. Beck-Friis J, von Rosen D, Kjellman BF, Ljunggren JG, Wetterberg L. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 1984;9:261-77.